Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR-O-MICS: Precision Imaging in Ovarian Cancer
NCT06084195Recruiting
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Dec 2023
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Institut du Cancer de Montpellier. Primary endpoint: Integration of in vivo and ex vivo MRI with histology and molecular assessments. Started Dec 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06084195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06084195.